Clinical trial

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

NCT01526733

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-12-01

PhasePHASE4

Study timeline

Study start (unknown)2011-12-01Date precision: month

Registry last updated2019-02-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetes Mellitusunresolved

Interventions

Sham InjectionDRUG

Recombinant human hyaluronidase PH20DRUG

Insulin aspartDRUG

Insulin lisproDRUG · verified · RxNorm: insulin lispro

Sponsors & collaborators

Halozyme Therapeuticslead sponsor

Mapped research locations

Chula VistaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01526733 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.